STAT

Telehealth can help fight the novel coronavirus, but U.S. challenges could limit its potential

Telehealth can help fight the novel #coronavirus, but there are obstacles in the U.S. that could limit the technology's potential.

As the world braces for the spread of disease caused by the new coronavirus, public health officials are calling on clinicians and health systems to embrace a set of tools that are technically already within reach: smartphones.

This week, officials from both the Centers for Disease Control and the World Health Organization urged hospitals and clinics to expand their use of telehealth services — also known as remote or virtual care — to help triage the sick and keep the worried well out of already-crowded medical facilities.

In the eyes of many clinicians and public health experts, telehealth’s moment has arrived. 

“Telehealth can be a force multiplier that helps protect health workers and extends their reach, and should absolutely be seized upon,” Eric Perakslis, a Rubenstein Fellow at Duke University focusing on data science who previously led the

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks